Loading viewer...
investor_presentation
Format: PDF investor_presentation
Regeneron Pharmaceuticals' November 2023 corporate presentation outlines the company's pipeline of marketed products and product candidates, including EYLEA, Dupixent, Libtayo, and multiple late-stage investigational therapies. The presentation contains forward-looking statements regarding regulatory milestones, commercial launches, and financial guidance for the biopharmaceutical company.
investor_presentation
23 Pages
investor_presentation
21 Pages
Zebra Technologies
Sonoma Pharmaceuticals Investor Presentation — June 2018
investor_presentationinvestor_presentation
8 Pages
Sonoma Pharmaceuticals, Inc.
CapitaLand Investment 2023 Non-deal Roadshow Kuala Lumpur
investor_presentationinvestor_presentation
63 Pages
CapitaLand Investment Limited
